FDA Approves Omvoh by Eli Lilly for Ulcerative Colitis
Eli Lilly and Company has announced that the U.S. Food and Drug Administration (FDA) has approved a new single-injection, once-monthly maintenance option (200 mg/2...
Novartis to Acquire Avidity Biosciences in $12 Billion Deal
Swiss pharmaceutical company Novartis announced that it has reached an agreement to acquire U.S.-based biotechnology firm Avidity Biosciences in a cash deal valued at...
AstraZeneca Unveils Expanded Manufacturing Facility in Texas
AstraZeneca has opened an expanded manufacturing facility in Coppell, Texas, following a $445m investment aimed at meeting growing global demand for its hyperkalaemia therapy,...
FDA Approves Novo Nordisk’s Rybelsus Oral GLP-1 Therapy
Novo Nordisk has announced that the US Food and Drug Administration (FDA) has granted approval for Rybelsus®, the only oral GLP-1 therapy, to reduce...
FDA Approves Amgen and AstraZeneca’s TEZSPIRE for CRSwNP
Amgen and AstraZeneca have announced that the U.S. Food and Drug Administration (FDA) has granted approval for TEZSPIRE® (tezepelumab-ekko) as an add-on maintenance therapy...
FDA Clears Genentech’s Gazyva for Lupus Nephritis in Adults
Genentech, part of the Roche Group, has announced that the U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab) for adults with active...
FDA Approves Celltrion’s EYDENZELT for Retinal Diseases
Celltrion, Inc. said the U.S. Food and Drug Administration (FDA) has approved EYDENZELT® (aflibercept-boav), a biosimilar of EYLEA® (aflibercept), for several retinal conditions. These...
Subscribe Our Newsletter
White Papers
The Future of Digital Health
The pharmaceutical industry is acutely aware that the future of health and care, particularly in the United States, are trending toward a digital revolution....
Five Best Practices to Deliver Exceptional Multichannel Experiences
A one-size-fits-all customer journey no longer works. In the age of the consumer, the quality of the interaction is paramount. In this paper, we...
The Impact and Use of Social Media in Pharmacovigilance
Social media presents new channels and methods for biopharmaceutical companies to move away from traditional pharmacovigilance (PV) systems and safety reporting methods towards more...